Conferences / Events
Vaccine Development Center of San Antonio Conference
Infection, Immunity and Vaccines
| Date: | November 16, 2018 | 8:30 am – 5:00 pm November 17, 2018 | 8:30 am – 3:30 pm |
| Location: | Eilan Hotel & Spa 18603 La Cantera Terrace San Antonio, TX 78256 |
| Register Here |
| Deadlines | Poster Requirements » Poster size: 36″ x 36″ or 36″ x 48″ or 36″ x 54″ » Must have at least two (2) authors » Abstract limited to 250 words maximum » May use either results or methodology |
| Abstract Deadline: November 2, 2018 |
|
| Registration Deadline: November 9, 2018 |
| Accommodations Click here to book a room at the Eilan. (Note: the $22 Destination Amenity Fee has been waived for attendees; however, it still prints out on the guest confirmation – please disregard.) |
| Shuttle Service Shuttle service will be available from UT Health San Antonio and UTSA. Click here for shuttle times. |
Keynote Speakers
“Vaccine Research to Combat Infectious Disease Threats to the U.S. Military: Past, Present, and Future”
Dr. Brian Agan, Assistant Professor and Director of HIV/STI Research, Uniformed Services University Infectious Disease Clinical Research Program
The Infectious Disease Clinical Research Program (IDCRP) is committed to reducing the impact of infectious diseases in the military population through collaborative clinical research. The IDCRP HIV Research Area is focused on ensuring the long term health and function of infected service members and beneficiaries as well as primary HIV and secondary STI prevention efforts.
“T-Cell Dependent Humoral Immunity”
Dr. Joseph Craft, Paul B. Beeson Professor of Medicine, Professor of Immunobiology, and Rheumatology Section Chief, Yale School of Medicine
Dr. Craft directs a research laboratory devoted to understanding the immune response to pathogens and vaccines, and dissecting and treating autoimmune diseases, such as systemic lupus erythematosus. He is Director of the Investigative Medicine Program at Yale, a unique program designed to provide Ph.D. training for physicians. He is co-founder of L2Diagnostics, formed in partnership with Yale University and devoted to discovery of new diagnostics and therapeutic targets for immunological and infectious diseases.
“Genomics-Driven Vaccine Development against Urinary Tract Infection”
Dr. Harry L.T. Mobley, Frederick G. Novy Distinguished University Professor and Chair, University of Michigan Medical School
Dr. Mobley’s laboratory is interested in the molecular mechanisms of bacterial pathogenesis. They are studying virulence mechanisms of uropathogenic Escherichia coli and Proteus mirabilis that cause urinary tract infection and are using a large-scale selection process that incorporates bioinformatic, genomic, transcriptomic, and proteomic screens to identify, in an unbiased manner, potential vaccine candidates. They are also identifying immunological correlates of protection.
“The Dot/lcm Secretion System: A Master Manipulator of Host Cell Functions”
Dr. Craig Roy, Waldemar Von Zedtwitz Professor of Microbial Pathogenesis and of Immunobiology and Vice-Chair of Department of Microbial Pathogenesis, Yale School of Medicine
Research in the Roy laboratory focuses on the host-pathogen interface. Using multi-disciplinary approaches, his laboratory has discovered many novel mechanisms that intracellular pathogens use to modulate host membrane transport pathways, which allow these pathogens to evade cell autonomous defenses and create novel organelles that permit bacterial replication.
“The Impact of Obesity on Influenza Pathogenesis, Evolution and Vaccination”
Dr. Stacey L. Schultz-Cherry, Deputy Director, World Health Organization Collaborating Center for Studies on the Ecology of Influenza in Animals and Birds
Dr. Schultz-Cherry is internationally known for her expertise in host factors in influenza virus pathogenesis and has provided fundamental contributions to microbiology and human and animal health through cutting-edge molecular and pathogenesis studies of influenza virus and astroviruses. Dr. Schultz-Cherry is a faculty member of the Department of Infectious Diseases at the St. Jude Children’s Research Hospital.